<DOC>
	<DOCNO>NCT01063218</DOCNO>
	<brief_summary>The main goal present study evaluate decrease necessity topic corticoid usage control outbreak light moderate atopic dermatitis use correct emollient .</brief_summary>
	<brief_title>Evaluation Cetaphil Advanced Usage Control Light Moderate Atopic Dermatitis , Attempt Reduce Necessity Topic Corticoids Application</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>Male Female patient 2 10 year old . light moderate sign acute/ subacute eczema activity . Subjects present inflammatory lesion , erythema , edema , eschar , excoriation lichen . Subjects present light moderate dryness . Subjects present serious systemic disease Subjects medical history regard serious asthma Subjects know suspect allergy one investigational product Subjects acute atopic eczema activity , need systemic antibiotic Subjects sign active infection skin Subjects whose parent legal guardian seem difficulty understand inform consent form ( ICF ) Female subject premenarche period . Subjects need topic corticoid medication interfere Atopic Dermatitis study . Patient washout period treatment le : injectable corticoid : 60 day systemic corticoid : 15 day topic corticoid : 8 day topic immunomodulator : 8 day antihistaminic : 48 hour</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Dermatitis , Atopic</keyword>
	<keyword>Corticoids , topic</keyword>
	<keyword>Corticosteroids</keyword>
</DOC>